Autopsy report · NCT01310140

Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features

“PI left Massachusetts General Hospital Inpatient service”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 8 months before it stopped.
• 14 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Massachusetts General Hospital

Sponsor type

University, hospital or other

Conditions

Major Depressive Disorder; Major Depressive Disorder w/ Psychotic Features; Metabolic Syndrome

Participants

14

Sites

1

Countries

United States

Trials that died the same way

• A Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy (ECT)
  “This was an inpatient study, but PI left inpatient service at MGH” (74% match in meaning)
• Post-marketing Surveillance Regarding Efficacy and Safety of SpaceOAR™
  “PI did leave hospital (retired)” (73% match in meaning)
• Aliskiren and Renin Inhibition in Diastolic Heart Failure
  “Difficulty in recruiting patients and then the PI left the institution” (66% match in meaning)
• Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
  “PI left institution, end of funding, clinic relocation, recruitment issues” (64% match in meaning)
• Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease
  “PI left Cleveland Clinic” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.